DEPO Financial Facts

Total selling, general and administrative expense: 27.08M
Total other income (expense): -6.25M
See Full Income Statement

Other long-term liabilities: 13.19M
Inventories: 7.29M
See Full Balance Sheet

DepoMed Inc. (DEPO) Earnings

  |   Expand Research on DEPO
Next EPS Date 5/8/15 *Est. EPS Growth Rate -70.8% *Last Qtr.
Average EPS % Beat Rate +165.6% Revenue Growth Rate +80.4% *Last Qtr.
Average % Move 1-Wk after EPS +2.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/23/15 Q414 $0.21$0.07 +$0.14$33.9M$18.8M N/A Details
11/5/14 Q314 $0.03-$0.04 +$0.07$51.5M$41.5M Details
8/6/14 Q214 -$0.01-$0.08 +$0.07$67.7M$38.03M Details
5/8/14 Q114 $0.30$0.10 +$0.20$76.54M$53.57M Details
3/6/14 Q413 $0.72-$0.21 +$0.93$18.79M$19.06M Details
11/5/13 Q313 $0.11$0.07 +$0.04$37.5M$35.55M = Details
8/7/13 Q213 $0.01-$0.05 +$0.06$30M$29.87M = Details
5/8/13 Q113 -$0.10-$0.06 -$0.04$26.2M$28.93M = Details